Petrobras Approves $1.2 Billion Biorefining Plant for Renewable Fuels
PBR sits 47% above its 52-week low of $11.43.
Summary
Petrobras approved a $1.2 billion investment for a new biorefining plant to produce bio-jet fuel and renewable diesel, advancing its energy transition strategy.
Key Events · Product Development and Regulatory · PBR
-
Final Investment Decision Approved
Petrobras's Board of Directors approved the Final Investment Decision (FID) for the RPBC Biorefining project, committing approximately US$1.2 billion.
-
New Renewable Fuel Production
The project will implement a dedicated plant at the Presidente Bernardes Refinery (RPBC) to produce up to 15,000 barrels per day of bio-jet fuel and renewable diesel.
-
Strategic Alignment and Timeline
This investment is part of the company's Business Plan 2026–2030 and aligns with its commitment to a just energy transition. Construction is expected to begin by the end of 2026, with start-up scheduled for 2030.
Analysis · PBR · Energy & Transportation
Petrobras has committed $1.2 billion to build a new biorefining plant, a significant investment representing over 1% of its market capitalization. This Final Investment Decision (FID) is a concrete step in the company's 2026-2030 strategic plan to diversify into renewable fuels like bio-jet fuel and renewable diesel, aligning with global energy transition goals and regulatory requirements. This move positions Petrobras for future growth in sustainable energy.
How filings like this one have moved
In the 30 days to Sep 22, 2026, 34.8% of the 1044 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PBR was trading at $16.82 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $102.4B. The 52-week trading range was $11.43 to $22.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.